🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
154

Quick answer

Takeda has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Ferric carboxymaltose

    Takeda

    Cardiac Failure

    approved small molecule active

    1 trial

  2. Fruquintinib

    Takeda

    Colorectal Cancer

    approved small molecule active

    1 trial

  3. Guanfacine hydrochloride (TAK-503)

    Takeda

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

  4. HYQVIA

    Takeda

    Primary Immunodeficiency Diseases (PID)

    approved mab completed

    2 trials

  5. Idursulfase

    Takeda

    Hunter Syndrome

    approved mab completed

    2 trials

  6. Ixazomib

    Takeda

    Relapsed and/or Refractory Multiple Myeloma

    approved small molecule terminated

    4 trials

  7. Lansoprazole

    Takeda

    Functional Dyspepsia

    approved small molecule terminated

    1 trial

  8. Lansoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    1 trial

  9. Lansoprazole (Prevacid)

    Takeda

    Zollinger-Ellison Syndrome

    approved small molecule completed

    1 trial

  10. Lanthanum carbonate

    Takeda

    Kidney Failure, Chronic

    approved small molecule completed

    6 trials

  11. Lanthanum carbonate

    Takeda

    Kidney Diseases

    approved small molecule terminated

    2 trials

  12. Leuprorelin

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  13. Leuprorelin Acetate Depot 3M

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  14. Lisdexamfetamine dimesylate

    Takeda

    Attention-deficit/Hyperactivity Disorder

    approved small molecule completed

    3 trials

  15. Lisdexamfetamine dimesylate

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  16. Lubiprostone

    Takeda

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  17. Lubiprostone

    Takeda

    Inflammatory Bowel Disease

    approved small molecule completed

    1 trial

  18. Lubiprostone

    Takeda

    Constipation

    approved small molecule completed

    7 trials

  19. MMX Mesalamine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    2 trials

  20. MMX mesalamine/ mesalazine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    1 trial

  21. Manidipine 20mg

    Takeda

    Hypertension

    approved small molecule terminated

    1 trial

  22. Maribavir

    Takeda

    Transplant Complication

    approved small molecule completed

    1 trial

  23. Metformin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  24. Midodrine HCl

    Takeda

    Symptomatic Orthostatic Hypotension

    approved small molecule completed

    1 trial

  25. Midodrine HCl

    Takeda

    Orthostatic Hypotension

    approved small molecule completed

    1 trial

  26. Midodrine Hydrochloride

    Takeda

    Hypotension, Orthostatic

    approved small molecule completed

    2 trials

  27. Mixed amphetamine salts (ADDERALL XR)

    Takeda

    ADHD

    approved small molecule completed

    1 trial

  28. NESINA ACT TAB. 25/15mg

    Takeda

    Diabetes

    approved small molecule active

    1 trial

  29. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial

  30. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  31. Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

    Takeda

    Hemophilia A

    approved mab completed

    2 trials

  32. Pantoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    3 trials

  33. Pantoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    2 trials

  34. Pioglitazone

    Takeda

    Nonalcoholic Steatohepatitis

    approved small molecule completed

    1 trial

  35. Pioglitazone

    Takeda

    Type II Diabetes Mellitus

    approved small molecule completed

    1 trial

  36. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  37. Pioglitazone

    Takeda

    Bone Metabolism

    approved small molecule completed

    1 trial

  38. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials

  39. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  40. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial

  41. Pioglitazone

    Takeda

    Metabolic Syndrome

    approved small molecule completed

    1 trial

  42. Pioglitazone 15mg

    Takeda

    Inflammation

    approved small molecule completed

    1 trial

  43. Pioglitazone and insulin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    2 trials

  44. Pioglitazone and metformin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    5 trials

  45. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial

  46. Placebo

    Takeda

    Post-Traumatic Stress Disorder

    approved small molecule completed

    1 trial

  47. Placebo

    Takeda

    Chronic Insomnia

    approved small molecule terminated

    1 trial

  48. Prednisone

    Takeda

    Crohn's Disease

    approved small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

154 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.